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We developed handheld photoacoustic microscopy (PAM) to detect melanoma and determine tumor depth in nude
mice in vivo. Compared to our previous PAM system for melanoma imaging, a new light delivery mechanism is
introduced to improve light penetration. We show that melanomas with 4.1 and 3.7 mm thicknesses can be
successfully detected in phantom and in in vivo experiments, respectively. With its deep melanoma imaging ability
and handheld design, this system can be tested for clinical melanoma diagnosis, prognosis, and surgical planning for
patients at the bedside. © 2014 Optical Society of America
OCIS codes: (170.5120) Photoacoustic imaging; (170.3880) Medical and biological imaging; (170.3890) Medical optics
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Melanoma is a malignant tumor of melanocytes. It is now
the fifth most common cancer in the United States [1,2],
where there were about 76,690 men and women diag-
nosed with melanoma in 2013 alone [2,3]. Although mela-
noma accounts for less than 5% of all skin cancers [2], it
causes more than 75% of deaths related to skin cancer [1].
In addition, the incidence of melanoma is increasing
faster than that of any other cancer [4]. Consequently,
there is an increased demand for accurate diagnosis,
prognosis, and treatment of melanoma.
The thickness of a melanoma is a critical parameter
for determining definitive treatment and prognosis [5].
Based on its thickness, the tumor (T) classification in
the tumor-node-metastasis (TNM) staging system can
be further divided into T1 (≤1.0 mm), T2 (1.01–
2.0 mm), T3 (2.01–4.0 mm), and T4 (>4.0 mm) [2]. As
the thickness increases, so do the chances for developing
metastatic disease, and thus, disease mortality. Current
diagnoses are dependent upon clinical suspicion, sub-
sequent biopsy, and histologic examination. It has been
shown that clinical examination alone may miss certain
tumors, and conversely, many benign lesions may be
unnecessarily biopsied [6,7]. In trained hands, the use
of handheld dermoscopy in the clinic has aided in the
diagnosis of melanoma by facilitating the evaluation of
surface characteristics of pigmented lesions [8]. It does
not, however, enable the determination of tumor thick-
ness and vertical growth of the melanoma, which are
important tumor characteristics when it comes to deter-
mining surgical treatment. In fact, the surgeon is often
met with the confounding situation where a pigmented
lesion may be partially biopsied and the diagnosis of
melanoma is made. Consequently, the true tumor depth
may not be determined because of sampling only part of
the tumor, leading to an inaccurate measurement. Thus, a
wide local excision (WLE) based upon a provisional
tumor depth may not be appropriate, and a second sur-
gery may be required to adequately treat the tumor. Thus,
a precise in vivo measurement of tumor depth, prior to
definitive surgery, would facilitate appropriate patient
treatment and help avoid further surgeries.
In the past few years, several noninvasive imaging
techniques have been developed for melanoma diagno-
ses [5,6,9]. However, all of them have limitations. Optical
methods, such as dermoscopy [8], total-body photogra-
phy (TBP) [10], optical coherence tomography [11],
scanning confocal microscopy [12], and two-photon
microscopy [13], do not have sufficient penetration to
determine melanoma depth because they can image only
in the ballistic regime. High-frequency ultrasound can
provide deeper penetration than optical methods [14].
However, because there is often no sufficient difference
in acoustic impedance between melanoma and normal
tissues, the image contrast for melanoma is poor. Mag-
netic resonance imaging (MRI) and positron emission
tomography (PET) have also been used in melanoma
diagnoses [15,16]. However, they are both expensive
and have poor resolution in the skin. Meanwhile, PET
has to use tracers for sufficient contrast and can only
detect tumors as large as ∼1 cm in dimension, which
encompasses only a tiny set of T4 primary melanomas
and misses all T1–T3 ones.
Recently, photoacoustic microscopy (PAM) has shown
strong ability in detecting skin vasculatures with high
contrast and deep penetration [17,18]. In PAM, short
laser pulses illuminate the object. Following the
absorption of photons, ultrasonic waves are induced
thermoelastically through the photoacoustic (PA) effect
[19,20]. Because melanin in most melanomas has a very
broad and strong absorption spectrum, it can be imaged
by PAM with high contrast. Meanwhile, because acoustic
scattering is low in the tissue, high resolution can be
achieved with deep penetration.
Previously, we reported that cutaneous pigmented
lesions, melanoma, and the surrounding vasculature
could be successfully detected by using dual-wavelength
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PAM [21]. In that study, light was transmitted through the
whole melanoma, resulting in a high attenuation, with
only very few photons reaching the base of the melanoma
(true tumor depth). In the end, PA signals were very
strong from the surface of the tumor but very weak from
the deepest portion. The experimental results showed
that a melanoma phantom with a maximum thickness
of 1.27 mm could be imaged, which covered only the
T1 classification. Using a similar configuration, other
studies on melanoma detection can be found elsewhere
[22–24]. In this report, we describe a new PAM system
with more efficient light illumination. By allowing light
to bypass the center of the tumor, more photons reach
the inferior depth of the melanoma. Equally important,
this system is designed to be handheld, facilitating clini-
cal usage.
Figure 1(a) shows a schematic of the handheld PAM
system. A Q-switched pulsed laser (Brilliant B, Quantel,
Les Ulis, France) generates light at 532 nm at 10 Hz as the
input for the dye cell. The output light of the dye cell is at
650 nm wavelength, where melanoma has high absorp-
tion, but both blood and water have low absorption.
A lens couples the free-space light into an optical fiber
bundle (LightGuideOptics, Rheinbach, Germany), with
output fibers arranged in a circle around a focused ultra-
sonic transducer (IS2502HR, CTS Valpey, Elkhart, Indi-
ana). Compared to our previous PAM system, the light
is delivered into the tissue normally instead of obliquely.
Thus, the light propagates around the melanoma instead
of going through it. Since the surrounding tissue has high
optical scattering but low absorption, the light reaching
the bottom boundary of the melanoma is increased. The
incident beam has an annular shape with 8 mm inner and
20 mm outer diameters. The optical fluence on the skin
surface was estimated to be 15 mJ∕cm2, which was less
than the safety limit set by the American National
Standard Institute (ANSI) (20 mJ∕cm2). The transducer,
with 25 MHz central frequency and 100% nominal band-
width, detects the PA signals. The focal length and diam-
eter of the detector are 12.7 and 6.4 mm, respectively,
yielding a numerical aperture (NA) of 0.25. Both the
optical fibers and transducer are fixed on a motorized
translation stage [Fig. 1(b)]. Each laser pulse generates
a one-dimensional depth-resolved image (A–line). A
two-dimensional cross sectional image is acquired by
linear scanning of the region of interest. As shown in
Figs. 1(a) and 1(b), the motor, translation stage, ultra-
sonic transducer, and optical fibers are all incorporated
in a handheld probe for easy operation. A photograph of
the handheld probe is shown in Fig. 1(c).
We use Monte Carlo simulations to show the advan-
tage of the new light illumination mechanism [25].
Figure 2(a) represents the old light illumination mecha-
nism (hereinafter referred to as case 1). The incident
angle was set to 45°, which was typical in the previous
PAM system. Figure 2(b) shows the new light illumina-
tion mechanism (hereinafter referred to as case 2). In
both simulations, the same incident energies were used.
The same melanoma phantom, with 1 mm thickness and
6 mm diameter, was used in both simulations. The
simulation parameters (absorption coefficient of the
melanoma phantom, 70 cm−1; absorption coefficient of
the background, 0.1 cm−1; scattering coefficients of the
melanoma phantom and background, 100 cm−1; scatter-
ing anisotropy of the melanoma phantom and back-
ground, 0.9) were selected based on normal tissue
optical properties at 650 nm wavelength [26,27]. As
shown in Fig. 2(c), in case 1, the specific optical absorp-
tion (Ae) decreases sharply in the melanoma phantom in
the depth direction. However, as shown in Fig. 2(d), in
case 2, Ae actually increases in the melanoma phantom
in the depth direction. As shown in Figs. 2(a)–2(d), the
same black-dashed-square area was chosen to calculate
an average Ae at the bottom boundary of the melanoma
phantoms for comparison between case 1 and case 2. The
average Ae is shown in Fig. 2(e). Although the average Ae
at the bottom boundary of the melanoma in the black-
dashed-square area was maximized by aligning the light
beam in case 1 [shown in Fig. 2(a)], it is still 1660 times
weaker than that in case 2. In both thermal and stress
Fig. 1. Experimental handheld photoacoustic microscopy
(PAM) system. (a) Schematic of the handheld PAM system.
(b) Components held by the translation stage in the handheld
probe. (c) Photograph of the handheld probe.
Fig. 2. Monte Carlo simulations of the old and new PAM sys-
tems for melanoma imaging. Melanoma phantom and light illu-
mination methods used in the simulations of (a) the old and
(b) the new systems. The red arrows show the incident angles
and areas of the light used in the Monte Carlo simulations.
Specific heat absorption (Ae) distributions in (c) the old and
(d) the new PAM systems with the same incident energy.
(e) Averaged Ae in the black-dashed-square areas [shown in
(a)–(d)] at the bottom boundary of the melanoma phantoms
in (c) blue line and (d) red dotted line, showing that the
melanoma is much more strongly illuminated at the bottom
boundary using the new PAM system.
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confinements, the PA signal is proportional to Ae. Thus,
the PA signal in case 2 is 1660 times stronger than that in
case 1. Because the light delivery is the only difference
between the systems, their noise levels should be the
same. Thus, the corresponding signal-to-noise ratio of
the melanoma at the bottom boundary in the black-
dashed-square area in case 2 is 1660 times greater than
that in case 1. The results show that, with the new
illumination mechanism, the bottom boundary of the
melanoma can be much more sensitively detected.
We first used a human hair as a line target to measure
the lateral resolution of this handheld PAM system. As
shown in Fig. 3(a), the full width at half-maximum
(FWHM) of the line spread function indicates a
lateral resolution of 230 μm. Because of the large
thickness of the hair (80 μm), the measured lateral res-
olution is slightly larger than the theoretical value
(0.72λ0∕NA  173 μm, where λ0 is the center acoustic
wavelength of the transducer) [28]. We next used a thin
ink layer to measure the axial resolution. Taking the
FWHM of the PA amplitude in the axial direction, we
estimated the axial resolution as 59 μm [Fig. 3(b)], which
is close to the theoretical value (0.88vs∕Δf  53 μm,
where vs is the sound speed in soft tissue, and Δf is
the frequency bandwidth of the transducer) [29].
Phantom experiments were conducted to demonstrate
the ability of the handheld PAM system to measure deep
melanomas. Three different diameters (7, 9.5, and
14 mm) of melanoma phantoms were prepared with var-
ied thicknesses, shown in Figs. 4(a)–4(c). All the phan-
toms were made from a black ink and gelatin mixture,
which had an absorption coefficient of 70 cm−1 at
650 nm, close to the real melanoma absorption coeffi-
cient. The background was made of a gelatin and intra-
lipid mixture with a high scattering coefficient to mimic
real tissue. As shown in Figs. 4(a)–4(c), our handheld sys-
tem successfully detected both the top and bottom boun-
daries of all the melanoma phantoms. The maximum and
minimum detected thicknesses of the phantoms were 0.7
and 4.1 mm, respectively. Thus, melanoma phantoms
with all the T-classifications in the staging system have
been measured. Figure 4(d) shows that our measured
thicknesses agreed well with the preset values. Thus,
the handheld PAM system can image deeply seated mela-
noma phantoms with high accuracy.
We also imaged mice with melanoma to show the
in vivo detection ability of the handheld PAM system.
Here we focused only on imaging deep melanoma to
show the advantage of the new PAM system over our
previous system. Melanoma B16 cells were subcutane-
ously injected into a nude mouse on the dorsal side
(Hsd:Athymic Nude-Foxn1NU, Harlan Co.; body weight:
20 g) to grow melanoma in the skin. All experimental
animal procedures were carried out in conformity with
the laboratory animal protocol approved by the School
of Medicine Animal Studies Committee of Washington
University in St. Louis. During image acquisition, the
animal, warmed by an infrared lamp, was kept motion-
less using a breathing anesthesia system (E–Z Anes-
thesia, Euthanex). Figures 5(a) and 5(b) show that a
melanoma with 3.66 mm thickness was imaged by our
handheld system. Both the top and bottom boundaries
of the melanoma and the skin surface can be clearly seen.
0 0.5 1 1.5 2 2.50
0.2
0.4
0.6
0.8
1
x (mm)
No
rm
al
iz
ed
 P
A 
am
pl
itu
de
0 100 200 300 4000
0.2
0.4
0.6
0.8
1
z (µm)
N
or
m
al
iz
ed
 
PA
 
am
pl
itu
de
)b()a(
Fig. 3. Spatial resolutions of the current PAM system. PA am-
plitudes in (a) the lateral x and (b) the axial z directions. The
full widths at half-maximum are 230 μm in (a) and 59 μm in (b).
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Fig. 4. Handheld PAM of melanoma phantoms. Photos of
melanoma phantoms with different diameters [(a) 7 mm,
(b) 9.5 mm, and (c) 14 mm]. (a1)–(a4), (b1)–(b4), and
(c1)–(c4): PAM images of different thicknesses of melanoma
phantoms with the same diameter as in (a), (b), and (c), respec-
tively. (d) Measured thicknesses of melanoma phantoms versus
preset thicknesses.
Fig. 5. Handheld PAM of melanoma in a nude mouse in vivo.
(a) PAM image of the melanoma clearly showing both the top
and bottom boundaries. (b) The same PAM image as (a). The
red dots outline the melanoma according to the shape of the
excised melanoma (red dots) in its photograph (c). Photograph
of the melanoma taken in vivo (d).
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Shown in Fig. 5(c), the real thickness of the melanoma
was measured to be 3.75 mm after excision, which is very
close to our noninvasive measurement. A photograph of
the melanoma in vivo is shown in Fig. 5(d). Therefore,
the handheld PAM system can accurately detect the
depth of deeply seated melanoma in vivo.
Compared to our previous PAM system for melanoma
imaging, the new system can detect the depth of thicker
melanomas by bypassing light around the tumor. In
addition, a handheld design makes our new PAM system
more suitable for clinical application. As shown in the
phantom experiment, melanoma as thick as 4.1 mm
can be detected, and in the in vivo experiment, mela-
noma with 3.75 mm thickness was imaged. Our measure-
ments also show very high accuracy. As important, the
improvement of the handheld system includes increasing
the imaging speed. The current system employs a 10 Hz
laser, which limits the imaging speed. Ten seconds is
needed to scan a 10 mm length along the lateral direction
with a step size of 100 μm. For clinical use, a rapid
imaging system is always preferred, which can be
achieved by using a pump laser with high pulse repetition
rate (e.g., 1 kHz) [17]. We propose that the use of hand-
held PAM imaging, to aid in the determination of tumor
depth, will facilitate the surgical treatment management
of melanoma.
The authors would like to thank Prof. James Ballard
for manuscript editing. This work was sponsored in part
by National Institutes of Health grants DP1 EB016986
(NIH Director’s Pioneer Award), R01 CA186567 (NIH
Director’s Transformative Research Award), R01
EB016963, and R01 CA159959. L. W. has a financial inter-
est in Microphotoacoustics, Inc. and Endra, Inc., which,
however, did not support this work. K. M. has a financial
interest in Microphotoacoustics, Inc.
References
1. A. F. Jerant, J. T. Johnson, C. D. Sheridan, and T. J. Caffrey,
Am. Fam. Physician 62, 357 (2000).
2. E. M. Dunki-Jacobs, G. G. Callendar, and K. M. McMasters,
Curr. Probl. Surg. 50, 351 (2013).
3. American Cancer Society, http://www.cancer.org/
acs/groups/content/@epidemiologysurveilance/documents/
document/acspc‑036845.pdf (2013).
4. K. M. Rubin, J. Dermatol. Nurses Assoc. 2, 6 (2010).
5. L. Smith and S. MacNeil, Skin Res. Technol. 17, 257 (2011).
6. P. Guitera and S. W. Menzies, Expert Rev. Anticancer Ther.
11, 715 (2011).
7. I. H. Wolf, J. Smolle, H. P. Soyer, and H. Kerl, Melanoma
Res. 8, 425 (1998).
8. C. Benvenuto-Andrade, S. W. Dusza, A. L. C. Agero, A.
Scope, M. Rajadhyaksha, A. C. Halpern, and A. A.
Marghoob, Arch. Dermatol. 143, 329 (2007).
9. M. A. Calin, S. V. Parasca, R. Savastru, M. R. Calin, and S.
Dontu, J. Cancer Res. Clin. Oncol. 139, 1083 (2013).
10. A. C. Halpern, Semin. Cutan. Med. Surg. 22, 2 (2003).
11. T. Gambichler, P. Regeniter, F. G. Bechara, A. Orlikov, R.
Vasa, G. Moussa, M. Stucker, P. Altmeyer, and K. Hoffmann,
J. Am. Acad. Dermatol. 57, 629 (2007).
12. S. Segura, S. Puig, C. Carrera, J. Palou, and J. Malvehy,
J. Am. Acad. Dermatol. 61, 216 (2009).
13. E. Dimitrow, M. Ziemer, M. J. Koehler, J. Norgauer, K.
Konig, P. Elsner, and M. Kaatz, J. Invest. Dermatol. 129,
1752 (2009).
14. W. Dummer, H. J. Blaheta, B. C. Bastian, T. Schenk, E. B.
Brocher, and W. Remy, Arch. Dermatol. 131, 279 (1995).
15. J. Bittoun, B. Querleux, and L. Darrasse, NMR Biomed. 19,
723 (2006).
16. T. Z. Belhocine, A. M. Scott, E. Even-Sapir, J. L. Urbain, and
R. Essner, J. Nucl. Med. 47, 957 (2006).
17. Y. Zhou, J. J. Yao, and L. H. V. Wang, Opt. Lett. 38, 2592
(2013).
18. L. H. V. Wang and S. Hu, Science 335, 1458 (2012).
19. D. Razansky, C. Vinegoni, M. Distel, R. Ma, N. Perrimon,
R. W. Koster, and V. Ntziachristos, Nat. Photonics 3, 412
(2009).
20. Y. Zhou, J. Yao, K. I. Maslov, and L. V. Wang, J. Biomed. Opt.
19, 37001 (2014).
21. J. T. Oh, M. L. Li, H. F. Zhang, K. Maslov, G. Stoica, and
L. H. V. Wang, J. Biomed. Opt. 11, 034032 (2006).
22. C. Kim, E. C. Cho, J. Chen, K. H. Song, L. Au, C. Favazza, Q.
Zhang, C. M. Cobley, F. Gao, Y. Xia, and L. V. Wang, ACS
Nano 4, 4559 (2010).
23. H. F. Zhang, K. Maslov, G. Stoica, and L. V. Wang, Nat.
Biotechnol. 24, 848 (2006).
24. J. Staley, P. Grogan, A. K. Samadi, H. Cui, M. S. Cohen, and
X. Yang, J. Biomed. Opt. 15, 040510 (2010).
25. L. H. Wang, S. L. Jacques, and L. Q. Zheng, Comput.
Methods Programs Biomed. 54, 141 (1997).
26. S. L. Jacques and D. J. Mcauliffe, Photochem. Photobiol. 53,
769 (1991).
27. L. V. Wang and H. Wu, Biomedical Optics: Principles and
Imaging (Wiley, 2007).
28. E. W. Stein, K. Maslov, and L. H. V. Wang, J. Appl. Phys. 105,
102027 (2009).
29. C. Zhang, Y. Zhou, C. Y. Li, and L. H. V. Wang, Appl. Phys.
Lett. 102, 163702 (2013).
4734 OPTICS LETTERS / Vol. 39, No. 16 / August 15, 2014
